Short-term mechanical circulatory support by veno-arterial extracorporeal membrane oxygenation in the management of cardiogenic shock and end-stage heart failure

Expert Review of Cardiovascular Therapy

Volumn 12, Issue 2, 2014, Pages 145-153

  Brugts, Jasper J ^a   Caliskan, Kadir ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

assist device; cardiogenic shock; ECMO; heart failure; LVAD; mechanical circulatory support

Indexed keywords

DOBUTAMINE;

ACUTE HEART INFARCTION; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; EXTRACORPOREAL OXYGENATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMPLANTATION; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; MORTALITY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; REVASCULARIZATION; TREATMENT CONTRAINDICATION;

CARDIOTONIC AGENTS; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; SHOCK, CARDIOGENIC; SURVIVAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893061682     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2014.880051     Document Type: Article

References (40)

1. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999;341(9):625-34
2. Gheorghiade M, Zannod F, Sopko G, et al. Acute heart failure syndromes: current state and framework for future research. Circulation 2005;112:3958-68
3. Hands ME, Rutherford JD, Muller JE, et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostics factors. The MILIS Study Group. J Am Coll Cardiol 1989;14:40-6
4. Holmes DR Jr. Cardiogenic shock: a lethal complication of acute myocardial infarction. Rev Cardiovasc Med 2003;4:131-5
5. Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975-1988. N Engl J Med 1991;325:1117-22
6. Menon V, Hochman JS, Stebbins A, et al. for the GUSTO investigators. Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J 2000;21: 1928-36
7. Carnendran L, Abboud R, Sleeper A, et al. Trends in cardiogenic shock: report from the SHOCK Study. Eur Heart J 2001;22: 472-8
8. Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162-8
9. McMurray JJ, Adamopoulos S, Anker D. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-847
10. Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;62(16):e147-239
11. Menon V, Fincke R. Cardiogenic shock: a summary of the randomized SHOCK trial. Congest Heart Fail 2003;9:35-9
12. Aggarwal S, Slaughter MS. Acute myocardial infarction complicated by cardiogenic shock: role of mechanical support. Exp Rev Cardiovasc Ther 2008; 6(9):1223-35
13. Ferguson JJ, Cohen M, Freedman RJ, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol 2001;38(5):1456-62
14. Briguori C, Sarais C, Pagnotta P, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J 2003;145(4):700-7
15. Barron HV, Every NR, Parsons LS, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001;141(6):933-9
16. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. N Engl J Med 2012;367:1287-96
17. Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final month results of a randomised, open-label trial. Lancet 2013;382:1638-45
18. Cove ME, MacLaren G. Diagrammatic representation of peripheral veno-venous (VV-ECMO) and peripheral veno-arterial (VA-ECMO) extracorporeal membrane oxygenation. Crit Care 2010;14:235
19. Aggarwal S, Slaughter MS. Acute myocardial infarction complicated by cardiogenic shock: role of mechanical circulatory support. Expert Rev Cardiovasc Ther 2008;6:1223-35
20. Beckmann A, Benk C, Beyersdorf F, et al. Position article for the use of extracorporeal life support in adult patients. Eur J Cardiothorac Surg 2011;40:676-80
21. Rastan AJ, Dege A, Mohr M, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010;139:302-11
22. Doll N, Kiaii B, Borger M, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004;77:151-7
23. Madershahian N, Liakopoulos OJ, Wippermann J, et al. The impact of intraaortic balloon counterpulsation on bypass graft flow in patients with peripheral ECMO. J Card Surg 2009;24:265-8
24. Delnoij TS, Wetzels AE, Donker DW, et al. Peripheral venarterial extracorporeal life support despite impending left ventricular thrombosis: a bridge to resolution. J Cardiothorac Vasc Anesth 2013;27:e48-9
25. Beurtheret S, Mordant P, Paoletti X, et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J 2013;34(2):112-20
26. Kim H, Lim SH, Hong J, et al. Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. Resuscitation 2012;83:971-5
27. Formica F, Avalli L, Redaelli G, Paolini G. Interhospital stabilization of adult patients with refractory cardiogenic shock by veno-arterial extracorporeal membrane oxygenation. Int J Cardiol 2011;147:164-5
28. Sakamoto S, Taniguchi N, Nakajima S, Takahashi A. Extracorporeal life support for cardiogenic shock or cardiac arrest due to acute coronary syndrome. Ann Thorac Surg 2012;94:1-7
29. Hoefer D, Ruttmann E, Poelzl G, et al. Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg 2006;82:28-33
30. Mateen FJ, Muralidharan R, Shinohara RT, et al. Neurological injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol 2011;68:1543-9
31. Pieri M, Greco T, De Bonis M, et al. Diagnosis of infection in patients undergoing extracorporeal membrane oxygenation: a case-control study. J Thorac Cardiovasc Surg 2012;143:1411-16
32. Bisdas T, Beutel G, Warnecke G, et al. Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg 2011;92:626-31
33. Formica F, Avalli L, Colagrande L, et al. Extracorporeal membrane oxygenation to support adult patients with cardiac failure: predictive factors of 30-day mortality. Interact Cardiovasc Thorac Surg 2010;10: 721-6
34. Marasco SF, Lukas G, McDonald M. Review of ECMO support in critically ill adult patients. Heart Lung Circ 2008; 17(Suppl 4):S41-7
35. Alba AC, Rao V, Ivanov J, et al. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant 2009;28:827-33
36. Barge-Caballero E, Paniagua-Mart? MJ, Marzoa-Rivas R, et al. Usefulness of the INTERMACS scale for predicting outcomes after urgent heart transplantation. Rev Esp Cardiol 2011;64(3):193-200
37. Holman WL, Kormos RL, Naftel DC, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 2009;28(1):44-50
38. Barge-Caballero E, Segovia-Cubero J, Almenar-Bonet L, et al. Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry. Circ Heart Fail 2013;6(4):763-72
39. Boyle AJ, Ascheim DD, Russo MJ, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 2011;30:402-7
40. Constantinescu AA, Caliskan K, Manintveld OC. Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis. Eur J Heart Fail 2013; [Epub ahead of print]